Skip to main content
. 2021 Dec 24;29(1):68–76. doi: 10.3390/curroncol29010006

Figure 2.

Figure 2

Anti-spike Antibody Concentrations in Healthy Controls and Cancer Patients with Closely Matched Dosing Intervals (Average 60 Days versus 54 Days, Respectively), Following Two Doses of SARS-CoV-2 Vaccine. p-values are determined by Tukey test against healthy controls. HC: healthy controls; ST: solid tumor; HM: hematological malignancy.